We are upgrading the repository! The content freeze has been extended to December 11, 2024, when we expect the new repository to become available. New submissions or changes to existing items will not be allowed until after the new website goes live. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Exploring the Contributions of Local Health Departments in Land Use and Transportation Policy: Implications for Cross-sector Collaboration
Document Type
PosterPublication Date
2017-05-16Keywords
local health departmentsphysical activity
land use policy
transportation policy
Environmental Policy
Health Policy
Place and Environment
Recreation, Parks and Tourism Administration
Translational Medical Research
Transportation
Metadata
Show full item recordAbstract
Introduction: Transportation and land use policies can impact physical activity. Local health departments (LHDs) are encouraged to participate in land use and transportation policy processes, which are outside their traditional expertise. Cross-sector collaborations are needed, yet stakeholders’ perceptions of LHD involvement are not well-understood. This paper explores (1) the perceived value of LHD participation in transportation and land use decision-making and (2) potential contributions of LHDs to these processes among relevant stakeholders. Methods: Qualitative data were analysed from 49 semi-structured interviews conducted in 2015 and 2016. Participants were professionals representing land use planning (n=13), transportation/public works (n=11), public health (n=19), bike and pedestrian advocacy (n=4), and municipal administration (n=2). Two analysts conducted thematic analysis. Results: All respondents reported that LHDs offer valuable contributions to transportation and land use policy processes. Seven specific contributions were identified (inter-rater agreement 91%). Participants described LHD knowledge of the built environment impact on health (n=44); ability to incorporate the public health evidence-base and best practices into built environment processes (n=23); and ability to articulate the impact of land use and transportation decisions on vulnerable populations (n=8). Other potential contributions included increasing public support through public education (n=27) and convening partnerships within the community and across municipal departments (n=35) to advance policy buy-in and enactment. Ability to analyse a range of data that could inform policy (n=41) and providing resource support (e.g., grant writing, offering technical assistance (n=20)) were also described. Conclusions: LHDs can leverage their strengths to foster cross-sector collaborations that promote community physical activity opportunities. The results of these interviews are being used to inform the development of sustainable capacity building models for LHD involvement in built environment decision-making.DOI
10.13028/4tpb-r345Permanent Link to this Item
http://hdl.handle.net/20.500.14038/28232Rights
Copyright the Author(s)Distribution License
http://creativecommons.org/licenses/by-nc-sa/3.0/ae974a485f413a2113503eed53cd6c53
10.13028/4tpb-r345
Scopus Count
Related items
Showing items related by title, author, creator and subject.
-
Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017Garcia, Maria M.; Lenz, Kimberly J.; Greenwood, Bonnie C.; Angelini, Michael C.; Thompson, Tyson; Clements, Karen M.; Mauro, Rose; Jeffrey, Paul L. (2019-08-01)Policies that address opioid dose limits may help to decrease high-risk opioid prescribing. We evaluated 3 sequential and progressive decreases in high-dose (HD) opioid limits implemented by Massachusetts Medicaid over 15 years. The study population included members ages 18 to 64 years with > /=1 claim for a schedule II opioid between January 2002 and March 2017. The 3 interventions consisted of prior authorization requirements for prescriptions exceeding the morphine equivalent dose (MED) HD dose limits: > 360 mg (intervention 1a and 1b), > 240 mg (intervention 2), and > 120 mg (intervention 3). A segmented regression evaluated the change in natural log of the average daily MED (AD_MED). The natural log of the AD_MED decreased during the 6 quarters after intervention 1a (P < .001), immediately after intervention 1b (P=.0002), and continued to decrease over the following 8 quarters (P=.023). The natural log of the AD_MED decreased immediately after intervention 2 (P=.002) and again after intervention 3 (P < .001). The percentage of users exceeding the HD limits of 360 mg, 240 mg, and 120 mg MED decreased by 87.3%, 79.8%, and 75.2% from baseline, respectively. The natural log of the AD_MED decreased among members after implementation of 3 sequential and progressive HD prior authorization limits, as did the percentage of members exceeding each of the HD limits. PERSPECTIVE: This study demonstrates the longitudinal impact of a prior authorization policy-based HD limit in a Medicaid population. This study contributes to options for policymakers and other Medicaid programs as a potential strategy to assist in addressing the opioid epidemic.
-
Impact of a Pilot Outreach Program upon Provider Awareness and Prescribing of a Concerning Opioid Combination RegimenSantaniello, Briana; Pomfret, Thomas C.; Tesell, Mark A.; Trask, Nicole M.; Alper, Caroline J.; Clements, Karen M.; Palumbo, Vincent; Lenz, Kimberly; Jeffrey, Paul L. (2018-02-22)This pilot program was developed in response to a drug utilization review within a large Medicaid population that revealed some hazardous practices. Co-prescribing of opioids with benzodiazepines, gabapentin, and other stimulants occurred in more than 500 members, putting them at risk for additive central nervous system depression, misuse, abuse, and death from overdose. The poster presentation outlines the objectives, methods, and results of a telephonic outreach program that addressed these safety concerns. It captures prescriber awareness of the presence and risks of potentially deadly medication combinations among members in their care, with some intriguing results. Our experts provide health plans with framework and support to address the opioid epidemic head on with robust opioid medication management programs, evidence-based clinical guidelines, and prescriber outreach. Our interdisciplinary team’s innovative approach helps health plans decrease inappropriate opioid usage and while ensuring members maintain access to appropriate pain management. This presentation was given at the American Drug Utilization Review Society (ADURS) conference February 22-24, 2018 in Scottsdale, Arizona.
-
One State's Perspective on the Management of Hepatitis C DrugsLavitas, Pavel (2015-02-27)This presentation provides an overview of the hepatitis C virus monitoring program implemented for state Medicaid to contain costs and to promote optimal member care. Key clinical and economic outcomes of the monitoring program are highlighted and formulary management strategies for novel hepatitis C virus agents identified. Presented at the American Drug Utilization Review Society 2015 Conference.